New cancer drug heads to clinical trials
Tuesday, March 29, 2011 - 14:31
in Health & Medicine
A new study showed that the drug AT-406 effectively targets proteins that block normal cell death from occurring. Blocking these proteins caused tumor cells to die, while not harming normal cells. The researchers believe the drug has potential to treat multiple types of cancer.